LiPlasome Pharma
LiPlasome Pharma is a biotechnology company providing a liplasomal reformulation of anticancer drugs.
All edits
Edits on 10 Jun, 2022
Golden AI
Edits on 8 Apr, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patents assigned (count)
2
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (-2 properties)
Infobox
Edits on 26 Nov, 2021
Golden AI
Edits made to:
Infobox (+1 properties)
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+1 properties)
Edits on 12 May, 2021
Golden AI
Edits on 14 Apr, 2021
Konrad Kawka
Edits on 13 Apr, 2021
Konrad Kawka
Edits made to:
Description (+101 characters)
LiPlasome Pharma
LiPlasome Pharma is a biotechnology company providing a liplasomal reformulation of anticancer drugs.
Edits on 6 Oct, 2020
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
March 1, 2005
Edits on 17 Jul, 2020
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
8,010,000
Edits on 12 Feb, 2020
Golden AI
Edits on 24 Jul, 2019
Golden AI
Edits on 9 Jul, 2019
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Golden AI
Edits made to:
LiPlasome Pharma
LiPlasome Pharma is a biotechnology company providing a liplasomal reformulation of anticancer drugs.
Find more companies like LiPlasome Pharma
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
